State Street SPDR S&P Biotech ETF

XBI us
$155.03
▼ 1.02 (-0.65%)
Volume: 8,234,902 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 42
  • 21d momentum -7.9%
  • RSI 44
🎯 Pullback 62
  • Near lower Bollinger band
  • -2.6% vs 20MA
💎 Value 50
  • No fundamental data

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)44.2
MACD-0.571
MA trendMixed
ATR2.73%
21d mom.-7.9%
63d mom.-0.2%
vs 20MA-2.6%
RVOL(20)0.97×
52w low · 98 52w high · 170
-8.8% from 52-week high
20d support 152 · resistance 168

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap—
PER—
PBR—
PSR—
EPS—
ROE—
ROA—
Dividend yield—
Debt/Equity—
EV/EBITDA—
week1M3M6M1YYTD
-1.39% -7.72% +2.94% +25.93% +61.26% +28.42%

Valuation and profitability in USD. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
4/10
🐻 Bear
7/10

14d momentum -5.36%, daily vol 2.04%. State Street SPDR S&P Biotech ETF sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.